Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors or Recurrent Small Cell Lung Cancer
by on Wednesday, August 1st, 2012 | No Comments
Conditions: Recurrent Small Cell Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: tivantinib; Drug: topotecan hydrochloride; Other: laboratory biomarker analysis; Other: pharmacological study; Other: pharmacogenomic studies
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)
Recruiting – verified July 2012
Read the original: Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors or Recurrent Small Cell Lung Cancer